▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Marijuana leaves and money

May 29, 2019 by Keith Speights

Origin House Delivers Sizzling Revenue Growth Thanks to Its California Cannabis Brands and a Key Canadian Acquisition

Revenue skyrocketed for the cannabis brands and distribution company as the California cannabis market picked up steam and sales poured in from its acquisition of Canadian vape retailer 180 Smoke.

Man watching chart go up

May 29, 2019 by Keith Speights

Why Cara Therapeutics Stock Is Soaring Today

The biotech reported great late-stage clinical results for its lead drug candidate.

Businessman holding cash in front of his face

May 29, 2019 by Keith Speights

2 Billionaires Just Bought Aurora Cannabis Stock -- Should You?

It seems like everybody's loving Aurora these days, including some of the richest people in the world.

Big fish little fish

May 29, 2019 by Keith Speights

3 Things to Really Like About Canopy Growth's Latest Acquisition

The Canadian marijuana producer's recent small deal could be a bigger deal over the long run.

Shopping cart with money

May 29, 2019 by Keith Speights, Chuck Saletta, and Todd Campbell

3 Top Small-Cap Stocks to Buy Right Now

These companies don't seem to have much in common. But they could all deliver big gains for investors.

Robotic surgery

May 28, 2019 by Keith Speights

Why TransEnterix Stock Is Jumping Today

Japanese approval for its robotic surgical system provides a nice spark to the medical device stock.

Marijuana leaves with shadow of dollar sign

May 26, 2019 by Keith Speights

Which Smaller Marijuana Stock Is Most Likely to Join Aurora Cannabis and Canopy Growth at the Top?

Three candidates appear to be at the top of the list.

Hemp, bottle of oil, dropper

May 26, 2019 by Keith Speights

Better Marijuana Stock: Cronos Group vs. Green Thumb Industries

Which stock wins in a matchup between a leading Canadian marijuana producer and a top U.S. cannabis operator?

Castle with moat

May 26, 2019 by Keith Speights

3 Big Biotech Stocks That Warren Buffett Might Like

There's at least one thing about these biotechs that the Oracle of Omaha should find especially appealing.

Man with right and wrong decision signs

May 26, 2019 by Keith Speights

You Should Prepare to Be Wrong About Aurora Cannabis

Don't be too sure you know how the future for this top Canadian marijuana stock will unfold.

Amgen scientists

May 26, 2019 by Keith Speights

3 Charts Every Amgen Investor Needs to See

These charts show there's a new Amgen emerging.

Marijuana surrounding U.S. flag

May 26, 2019 by Keith Speights

Don't Expect Quick U.S. Marijuana Legalization Based on Polls Showing Support: There's a Big Gotcha

There's something the surveys don't reveal.

Marijuana close-up in greenhouse

May 25, 2019 by Keith Speights

Better Marijuana Stock: HEXO vs. Village Farms

These two up-and-coming Canadian marijuana stocks are flying high right now, but one appears to be the better pick over the long run.

DNA strand with cancer cell

May 23, 2019 by Keith Speights, Chuck Saletta, and Todd Campbell

3 Cancer Treatment Stocks to Buy Right Now

These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.

Chart going down with man looking

May 21, 2019 by Keith Speights

Why Mallinckrodt Stock Is Tanking Today

The company filed a lawsuit to stop a federal decision that could be very bad news for its top drug.

Hand holding up paper sheet with marijuana leaf with crowded street

May 21, 2019 by Keith Speights

Aurora Cannabis, Cronos Group, and Tilray Earnings Results Are In: Here's What They Could Mean for Canopy Growth

Based on its peers' results, Canopy Growth could be in for a pretty good quarter.

Marijuana leaf with question marks

May 19, 2019 by Keith Speights

Aurora Cannabis Had a Great Quarter -- but Here's What We Still Don't Know

Unanswered questions for the marijuana producer could keep the stock from flying as high as it could.

Scientists with DNA

May 20, 2019 by Keith Speights

Better Buy: Vertex Pharmaceuticals vs. Galapagos

Two rising biotech stocks. One clear long-term winner.

Doctor holding stethescope to line chart

May 19, 2019 by Keith Speights

3 Healthcare Stocks I'd Buy Right Now

They're leaders in their markets. And those markets should grow tremendously.

Soaring man and chart

May 19, 2019 by Keith Speights

3 Biotech Stocks That Soared Last Week: Are They Buys?

Can these high-flying biotech stocks keep the momentum going?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services